Abstract
The purpose of this study was to achieve a better therapeutic efficacy and patient compliance in the treatment for vaginitis. Clotrimazole (1%) has been formulated in a vaginal gel using the thermosensitive polymer Pluronic F127 (20%) together with mucoadhesive polymers such as Carbopol 934 and hydroxypropylmethylcellulose (0.2% for both). To increase its aqueous solubility., clotrimazole was incorporated as its inclusion complex with 1∶1 molar ratio with β-cyclodextrin. The inclusion complex was thoroughly characterized using various techniques, including 1H NMR spectroscopy, FT IR spectrophotometry, differential scanning calorimetry, scanning electron microscopy, phase solubility studies, and determination of stability constant (k1∶1). The gelation temperature and rheological behavior of different formulations at varying temperatures were measured. In vitro release profiles of the gels were determined in pH 5.5 citrate buffer. It was observed that complexation with cyclodextrin slowed down the release of clotrimazole considerably. Carbopol 934, on the other hand, was found to interact with β-cyclodextrin, inducing precipitation. As far as rheological properties are concerned, thermosensitive in situ gelling was obtained with formulations containing drug: cyclodextrin complex rather than with free drug. Thus, the optimum formulation for a controlled-release thermosensitive and mucoadhesive vaginal gel was determined to be clotrimazole: β-cyclodextrin 1% with 0.2% hydroxypropylmethylcellulose in Pluronic F127 gel (20%) providing continuous and prolonged release of active material above MIC values.
Similar content being viewed by others
References
Ritter W, Patzschke K, Krause U, Stettendorf S. Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. Chemotherapy. 1982;28:37–42.
Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS. Clotrimazole: a review of its antifungal activity and therapeutic efficacy. Drugs. 1975;9:424–447.
Deshpande AA, Rhodes CT, Danish M. Intravaginal drug delivery. Drug Dev Ind Pharm. 1992;18:1225–1279.
Wolfsson AD. Intravaginal drug delivery technologies. In: Rathbone M, ed. Modified-Release Drug Delivery Technology. New York, NY: Marcel Dekker; 2002:759–774.
Hardy E, Jimenes AL, de Padua KS, Zanewald LJD. Women’s preferences for vaginal antimicrobial contraceptives, III: choice of a formulation, applicator and packaging. Contraception. 1998; 58:245–249.
Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C, Rossi S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm. 2001;27:541–547.
Chang JY, Oh YK, Choi H, Kim YB, Kim CK. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm. 2002;241:155–163.
Chang JY, Oh YK, Kong HS, et al. Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive, gels in vaginitis. J. Control Release. 2002;82:39–50.
Chu JS, Amidon GL, Weiner ND, Goldberg AH. Mixture experimental design in the development of a mucoadhesive gel formulation. Pharm Res. 1991;8:1401–1407.
Park H, Robinson JR. Physicochemical properties of water insoluble polymers important to mucin/epithelial adhesion. J. Control Release. 1985;2:47–57.
Veyries ML, Couarrazze, G, Geiger S, et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999;192:183–193.
Desai SD, Blanchard J. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate, nanocapsules of pilocarpine. Drug Deliv. 2000;7:201–207.
Bochot A, Fattal E, Grossiord JL, Puisieux F, Couvreur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive, gel. Int J Pharm. 1998;162:119–127.
Kim EY, Gao ZG, Park JS, Li H, Han K. rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm 2002; 233:159–167.
Thompson DO. Cyclodextrins—enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst. 1997;14:1–104.
Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins, I: drug solubilization and stabilization. J Pharm Sci. 1996;85:1017–1025.
Challa R, Alka A, Javed A, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmScitech. 2005;6:E329-E357.
Hedges AR. Industrial applications of cyclodextrins. Chem Rev. 1998;98:2035–2044.
Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. Development of in situ gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm. 1998;165:33–44.
Miyazaki S, Nakamura T, Takada M. Thermo-sensitive sol-gel transition of Pluronic F-127. Yakuzaigaku. 1991;51:36–43.
Schmeider HJ, Hacket F, Rüdiger V, Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 1998; 98:1755–1785.
Loukas YL. Measurement of molecular association in drug: cyclodextrin inclusion complexes with imporved 1H NMR studies. J Pharm Pharmacol. 1997;49:944–948.
Djedaini F, Perly B. Anthraquinone sulphonate as a generalpurpose shift reagent for the NMR analysis of cyclodextrins. Magnet Res Chem 1990;28:372–374.
Djedaini F, Perly B. Nuclear magnetic resonance investigation of the stoichiometries in β-cyclodextrin:steroid inclusion complexes. J Pharm Sci. 1991;80:1157–1161.
Van Doorne H, Bosch EH, Lerk CF. Formation and antimicrobial activity of complexes of beta-cyclodextrin and some antimycotic imidazole derivatives. Pharm Weekbl Sci. 1988;10:80–85.
Blanco-Fuente H, Esteban-Fernandez B, Blanco-Mendez J, Otero-Espinar FJ. Use of β-cyclodextrins to prevent modifications of the properties of carbopol hydrogels due to carbopol-drug, interactions. Chem Pharm Bull (Tokyo). 2002;50:40–46.
Boulmedarat L, Grossiord JL, Fattal E, Bochot A. Influence of methyl β-cyclodextrin and liposomes on rheological properties of Carbopol®974 NF gels. Int J Pharm. 2003;254:59–65.
Anderson BC, Pandit NK, Mallapragada S. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J Control Release. 2001;70:157–167.
Stella VJ, Rao VM, Zannou EE, Zia V. Mechanisms of drug release from cyclodextrin complexes. Adv Drug Deliv Rev. 1999;36:3–16.
Memisoglu E, Bochot A, Ozalp M, Sen M, Duchene D, Hincal AA. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm Res. 2003;20:117–125.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: April 14, 2006
Rights and permissions
About this article
Cite this article
Bilensoy, E., Abdur Rouf, M., Vural, I. et al. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex. AAPS PharmSciTech 7, 38 (2006). https://doi.org/10.1208/pt070238
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/pt070238